Gavi, Unitaid and the Global Fund welcome WHO recommendation for world’s first malaria vaccine

06 October 2021

  • WHO recommendation for wider use of the […]

MEDIA RELEASE: A regional COVID response needs more from Australia

A REGIONAL COVID […]

Global Fund Results Report Reveals COVID-19 Devastating Impact on HIV, TB and Malaria Programs

GENEVA – The COVID-19 pandemic had a devastating impact on the […]

World Hepatitis Day 2021: Unitaid paving the way for hepatitis C elimination

Unitaid has invested more than US$ 45 million into hepatitis […]

Innovative agreement launches affordable, optimal second-line HIV treatment in low- and middle-income countries

COVAX and World Bank to Accelerate Vaccine Access for Developing Countries

FIND and Unitaid invest to support technology transfer and boost local production of COVID-19 rapid tests in low- and middle-income countries

Global Fund Applauds Switzerland’s Leadership in The Global Fight Against COVID-19

14 July 2021

GENEVA – The Global Fund to Fight AIDS, Tuberculosis […]

New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide

Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX